Hallek, Michael

COVID-19 Associated Pulmonary Aspergillosis

Koehler, P., Cornely, O. A., Böttiger, B. W., Dusse, F., Eichenauer, D. A., Fuchs, F., Hallek, M., Jung, N., Klein, F., Persigehl, T., et al. (2020) · Mycoses

Antifungal resistance and susceptibilityCOVID-19 Clinical Research Studies

Cited by 547

Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2

Girod, A., Ried, M., Wobus, C., Lahm, H., Leike, K., Kleinschmidt, J., Deléage, G., & Hallek, M. (1999) · Nature Medicine

Virus-based gene therapy researchRNA Interference and Gene Delivery

Cited by 405

The VP1 capsid protein of adeno-associated virus type 2 is carrying a phospholipase A2 domain required for virus infectivity

Girod, A., Wobus, C. E., Zádori, Z., Ried, M., Leike, K., Tijssen, P., Kleinschmidt, J. A., & Hallek, M. (2002) · Journal of General Virology

Virus-based gene therapy researchParvovirus B19 Infection Studies

Cited by 354

Monoclonal Antibodies against the Adeno-Associated Virus Type 2 (AAV-2) Capsid: Epitope Mapping and Identification of Capsid Domains Involved in AAV-2–Cell Interaction and Neutralization of AAV-2 Infection

Wobus, C. E., Hügle-Dörr, B., Girod, A., Petersen, G., Hallek, M., & Kleinschmidt, J. A. (2000) · Journal of Virology

Virus-based gene therapy researchViral Infections and Immunology Research

Cited by 273

Toll–Like Receptor 2–Mediated Innate Immune Response in Human Nonparenchymal Liver Cells Toward Adeno–Associated Viral Vectors

Hösel, M., Broxtermann, M., Janicki, H., Esser, K., Arzberger, S., Hartmann, P., Gillen, S., Kleeff, J., Stabenow, D., Odenthal, M., et al. (2012) · Hepatology

Virus-based gene therapy researchImmune Response and Inflammation

Cited by 219

Efficacy of venetoclax in relapsed chronic lymphocytic leukemia is influenced by disease and response variables

Roberts, A. W., Ma, S., Kipps, T. J., Coutre, S. E., Davids, M. S., Eichhorst, B., Hallek, M., Byrd, J. C., Humphrey, K., Zhou, L., et al. (2019) · Blood

Chronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and Treatment

Cited by 178

Combinatorial engineering of a gene therapy vector: directed evolution of adeno‐associated virus

Perabo, L., Endell, J., King, S., Lux, K., Goldnau, D., Hallek, M., & Büning, H. (2006) · The Journal of Gene Medicine

Virus-based gene therapy researchRNA Interference and Gene Delivery

Cited by 136

Genetic modifications of the adeno-associated virus type 2 capsid reduce the affinity and the neutralizing effects of human serum antibodies

Huttner, N. A., Girod, A., Perabo, L., Edbauer, D., Kleinschmidt, J. A., Büning, H., & Hallek, M. (2003) · Gene Therapy

Virus-based gene therapy researchRNA Interference and Gene Delivery

Cited by 124

Phase II Dose Escalation Study of Caspofungin for Invasive Aspergillosis

Cornely, O. A., Vehreschild, J. J., Vehreschild, M. J. G. T., Würthwein, G., Arenz, D., Schwartz, S., Heussel, C. P., Silling, G., Mahne, M., Franklin, J., et al. (2011) · Antimicrobial Agents and Chemotherapy

Antifungal resistance and susceptibilityAntibiotics Pharmacokinetics and Efficacy

Cited by 93

Vector Uncoating Limits Adeno-Associated Viral Vector-Mediated Transduction of Human Dendritic Cells and Vector Immunogenicity

Rossi, A., Dupaty, L., Aillot, L., Zhang, L., Gallien, C., Hallek, M., Odenthal, M., Adriouch, S., Salvetti, A., & Büning, H. (2019) · Scientific Reports

Virus-based gene therapy researchRNA Interference and Gene Delivery

Cited by 85

Optimization of stealth adeno-associated virus vectors by randomization of immunogenic epitopes

Maersch, S., Huber, A., Büning, H., Hallek, M., & Perabo, L. (2010) · Virology

Virus-based gene therapy researchRNA Interference and Gene Delivery

Cited by 50

Noncanonical Function of AGO2 Augments T-cell Receptor Signaling in T-cell Prolymphocytic Leukemia

Braun, T., Stachelscheid, J., Bley, N., Oberbeck, S., Otte, M., Müller, T. A., Wahnschaffe, L., Glaß, M., Ommer, K., Franitza, M., et al. (2022) · Cancer Research

T-cell and Retrovirus StudiesChronic Lymphocytic Leukemia Research

Cited by 14

Data from Noncanonical Function of AGO2 Augments T-cell Receptor Signaling in T-cell Prolymphocytic Leukemia

Braun, T., Stachelscheid, J., Bley, N., Oberbeck, S., Otte, M., Müller, T. A., Wahnschaffe, L., Glaß, M., Ommer, K., Franitza, M., et al. (2023)

T-cell and Retrovirus StudiesChronic Lymphocytic Leukemia Research

Cited by 0